课题基金 / 基金详情

A novel therapeutic treatment for Zellweger Spectrum Disorder

A novel therapeutic treatment for Zellweger Spectrum Disorder
齐薇格谱系障碍的新型治疗方法
批准号：
325192
负责人：
Kim Peter K
金额：
$11.66万
依托单位：
Hospital for Sick Children (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-02-01 至 2016-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=325192&lang=en
关键词：
Autophagy Inhibitor Drug Study Orphan Disease Peroxisome Biogenesis Disorder

项目摘要

项目成果

Kim Peter K的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Zellweger's Spectrum Disorder (ZSD) is a rare disease that affects children. Caused by the lack of an organelle called Peroxisomes, which are involved in breaking down of fats and toxins, there is presently no cure for this devastating disease. Like all o
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Selective Autophagy in Zellweger Spectrum Disorders
Peroxisome in Adipose Tissue Expansion
Regulation of Mitochondria by Membrane Contact Sites
Role of Pexophagy in Peroxisome Biogenesis Disorders
海外基金